X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (73) 73
humans (67) 67
female (48) 48
male (47) 47
alaska - epidemiology (43) 43
adult (42) 42
infectious diseases (37) 37
middle aged (36) 36
child, preschool (34) 34
infant (30) 30
immunology (29) 29
adolescent (28) 28
alaska (27) 27
child (26) 26
united-states (25) 25
aged (24) 24
children (24) 24
microbiology (22) 22
epidemiology (19) 19
infant, newborn (19) 19
infections (19) 19
risk factors (19) 19
abridged index medicus (16) 16
public, environmental & occupational health (15) 15
young adult (15) 15
aged, 80 and over (14) 14
pneumococcal infections - epidemiology (14) 14
alaska natives (13) 13
disease (13) 13
population (13) 13
research (13) 13
antimicrobial resistance (12) 12
gastroenterology & hepatology (12) 12
surveillance (12) 12
time factors (12) 12
carrier state - epidemiology (11) 11
infection (11) 11
prevalence (11) 11
risk-factors (11) 11
streptococcus pneumoniae (11) 11
alaska native (10) 10
cohort studies (10) 10
conjugate vaccine (10) 10
incidence (10) 10
pediatrics (10) 10
pneumococcal vaccines - administration & dosage (10) 10
retrospective studies (10) 10
carrier state - microbiology (9) 9
genotype (9) 9
health aspects (9) 9
hepatitis c (9) 9
impact (9) 9
pneumococcal infections - prevention & control (9) 9
vaccines (9) 9
virus-infection (9) 9
article (8) 8
bacteria (8) 8
hepacivirus - genetics (8) 8
hepatitis (8) 8
indians, north american (8) 8
infants (8) 8
rural population (8) 8
streptococcus pneumoniae - classification (8) 8
streptococcus pneumoniae - isolation & purification (8) 8
analysis (7) 7
biopsy (7) 7
follow-up studies (7) 7
helicobacter pylori (7) 7
heptavalent pneumococcal conjugate vaccine (7) 7
hospitalization - statistics & numerical data (7) 7
invasive pneumococcal disease (7) 7
microbial sensitivity tests (7) 7
nasopharynx - microbiology (7) 7
respiratory syncytial virus (7) 7
serotyping (7) 7
strains (7) 7
streptococcus pneumoniae - drug effects (7) 7
anti-bacterial agents - pharmacology (6) 6
antibodies (6) 6
bacterial infections and mycoses (6) 6
carriage (6) 6
colonization (6) 6
disease outbreaks (6) 6
drug resistance, bacterial (6) 6
efficacy (6) 6
helicobacter infections - epidemiology (6) 6
helicobacter pylori - isolation & purification (6) 6
immunization (6) 6
immunogenicity (6) 6
pneumococcal infections - microbiology (6) 6
pneumococcal vaccines - immunology (6) 6
prospective studies (6) 6
risk assessment (6) 6
streptococcus-pneumoniae (6) 6
vaccination (6) 6
age (5) 5
age factors (5) 5
anti-bacterial agents - therapeutic use (5) 5
antibiotics (5) 5
arctic medicine. tropical medicine (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Hepatology, ISSN 0270-9139, 07/2017, Volume 66, Issue 1, pp. 37 - 45
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 11/2015, Volume 34, Issue 11, pp. 1223 - 1229
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 6/2006, Volume 193, Issue 11, pp. 1487 - 1494
Journal Article
Journal Article
International Journal of Circumpolar Health, ISSN 1239-9736, 01/2016, Volume 75, Issue 1, pp. 30696 - 8
There have been few reports of hepatitis C virus (HCV) treatment results with interferon-based regimens in indigenous populations. To determine... 
pegylated interferon | longitudinal study | indigenous population | sustained virologic response | discontinuation | Discontinuation | Pegylated interferon | Indigenous population | Sustained virologic response | Longitudinal study | PLUS RIBAVIRIN | VIRUS-INFECTION | TELAPREVIR | COMBINATION THERAPY | INITIAL TREATMENT | IMPACT | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PEGINTERFERON ALPHA-2B | TRIPLE THERAPY | BOCEPREVIR | OUTCOMES | Hepacivirus - drug effects | Follow-Up Studies | Risk Assessment | Antiviral Agents - therapeutic use | Alaska Natives - statistics & numerical data | Humans | Middle Aged | Male | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Indians, North American - statistics & numerical data | Interferon-alpha - administration & dosage | Ribavirin - administration & dosage | Adult | Alaska | Female | Aged | Hepatitis C, Chronic - epidemiology | Drug Therapy, Combination | Longitudinal Studies | Substance abuse treatment | Liver diseases | Laboratories | Urban areas | Infections | Patients | Disease control | Consortia | Disease prevention | Genotype & phenotype | Hepatitis | Native peoples | Interferon | Liver cirrhosis | Multivariate analysis | Hepatology | Population | Native North Americans | Index Medicus
Journal Article
Journal Article
CLINICAL INFECTIOUS DISEASES, ISSN 1058-4838, 05/2018, Volume 66, Issue 9, pp. 1478 - 1479
Journal Article
International Journal of Circumpolar Health, ISSN 1239-9736, 01/2019, Volume 78, Issue 1, pp. 1608139 - 1608139
Recent reports have found a rise in Hepatitis C virus (HCV) infection in reproductive age women in the USA. Surveillance data suggests one group that is at... 
Hepatitis C | American Indian/Alaska Native | pregnancy | UNITED-STATES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Alaska Native | VIRUS-INFECTION | RISK-FACTORS | DISEASE | HCV | VERTICAL TRANSMISSION | PREVALENCE | American Indian
Journal Article
American Journal of Public Health, ISSN 0090-0036, 11/2008, Volume 98, Issue 11, pp. 2072 - 2078
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 2011, Volume 17, Issue 42, p. 4682
Journal Article
Journal Article
Journal Article
Journal Article